Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Zhou Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6430-2137; OpenAlex author ID A5101246570. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2014: 3 papers · 2015: 3 papers · 2016: 3 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 10

  1. CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-3… Co-author PMID 38058810↗
  2. Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. Last author DOI 10.1186/s13046-016-0317-z↗
  3. Erratum to: Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wasting. Last author DOI 10.1186/s13046-016-0342-y↗
  4. Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer. Last author DOI 10.7150/ijms.16734↗
  5. Pancreatic cancer stem cells. First author DOI 10.1007/springerreference_176015↗
  6. Novel blood-based microRNA biomarkers for diagnosis of pancreatic cancer: a meta-analysis. Co-author DOI 10.5301/tj.5000240↗
  7. Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation. Co-author PMID 26175941↗
  8. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Co-author DOI 10.1007/s13277-014-2185-5↗
  9. SUMO-specific protease 1 regulates pancreatic cancer cell proliferation and invasion by targeting MMP-9. Co-author DOI 10.1007/s13277-014-2598-1↗
  10. miR-212 promotes pancreatic cancer cell growth and invasion by targeting the hedgehog signaling pathway receptor patched-1. Co-author DOI 10.1186/1756-9966-33-54↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xinyu Huang · 6 shared papers, 2014–2023 · strength 0.45
  2. Hongcheng Wang · 3 shared papers, 2015–2023 · strength 0.32
  3. Xiongzhi Wangpu · 1 shared paper, 2023 · strength 0.20
  4. Yayun Zhu · 2 shared papers, 2015–2016 · strength 0.20
  5. Kate Nong · 3 shared papers, 2014 · strength 0.13
  6. Kaixing Ai · 3 shared papers, 2014 · strength 0.13
  7. Chenchao Ma · 3 shared papers, 2014 · strength 0.13
  8. Xiu−Yan Huang · 2 shared papers, 2016 · strength 0.12
  9. Qingcai Meng · 2 shared papers, 2015 · strength 0.11
  10. Yang Gao · 1 shared paper, 2016 · strength 0.10
  11. Bo Wu · 2 shared papers, 2014 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.